The Proceedings of the 49th Annual General Meeting (AGM) of Eiko LifeSciences Limited held on Tuesday, 22nd September, 2026 at 04:00 P.M. IST through Video Conferencing ('VC')/ Other Audio-Visual Means ('OAVM') is attached herewith.

Date: 22nd September, 2026 Corporate Services Department, BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001. Scrip Code: 540204 Subject: Proceedings of the 49th AGM of Eiko LifeSciences Limited held on Tuesday, 22nd September, 2026 at 04:00 P.M. (IST) Dear Sir/Madam, Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 and other applicable provisions and circulars issued by the SEBI from time to time, we enclose the summary of proceedings of the 49th AGM of Eiko LifeSciences Limited, held on Tuesday, 22nd September, 2026 at 04:00 P.M. (IST) as Annexure – I. You are requested to kindly take the afore-mentioned on record. Thanking You, For Eiko LifeSciences Limited Chintan Doshi Company Secretary and Compliance Officer Membership No: A36190 Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com Annexure-I PROCEEDINGS OF 49th ANNUAL GENERAL MEETING OF THE COMPANY The 49th Annual General Meeting (AGM) of Eiko LifeSciences Limited (“the Company”) was held on Tuesday, 22nd September, 2026 at 04:00 P.M. IST through Video Conferencing (‘VC’)/ Other Audio-Visual Means (‘OAVM’) in accordance with the provisions of the Companies Act, 2013, the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) read with relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India in this behalf. Proceedings of the meeting in brief: The Moderator welcomed all members to the 49th Annual General Meeting (AGM). With the requisite quorum present, then he introduced the following Directors and Key Managerial Personnel of the Company: Name Designation Mr. Laxmikant Kabra Chairman and Non-Executive Director Mr. Bhavesh Tanna Non-Executive Director Mr. Sumukh Vartak Whole-Time Director Mr. Rajkumar Baheti Independent Director Ms. Kajal Kothari Independent Director Mr. Suraj Gaikwad Additional Independent Director Mr. Jaid Kojar Chief Financial Officer Mr. Chintan Doshi Company Secretary & Compliance Officer All the Directors of the Company, Chairperson of the Audit Committee, Nomination and Remuneration Committee and Stakeholders’ Relationship Committee were present at the Meeting. The representatives of the Statutory Auditor, M/s P S V Jain & Associates, Chartered Accountants, Secretarial Auditor, M/s Shravan A. Gupta & Associates, along with representative of Scrutiniser were also present at the Meeting via VC. Members Present: The meeting was attended by 25 members through VC / OAVM. The members were informed of some of the basic rules relating to the AGM. inter-alia, stated the following: i. The Facility for joining this meeting through video conference or other audio-visual means was made available for the members on a first-come-first-served basis. The Register of Directors and KMP, the Register of Contracts or Arrangements, was made available electronically for inspection by the members during the AGM. Members seeking to inspect such documents were requested to send their requests at investor.relations@eikolifesciences.com. As the AGM was held through video conference, the facility for appointment of proxies by the members was not applicable and hence the proxy register for inspection was not available. ii. Members were requested to refer to the Instructions provided in the notice for a seamless participation through video conference. In case members faced any difficulty, they were requested to reach out on the helpline numbers of the RTA, mentioned in the notice to this AGM. Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com Thereafter, the following items of business as per the Notice of AGM were transacted at the meeting: Sr. Particulars Type of No. Resolutions To receive, consider and adopt the Audited Standalone and Consolidated Financial 1 Ordinary Statements of the Company for the Financial Year ended 31st March, 2026 together with the Reports of the Board of Directors and Auditors thereon. 2 To re-appoint Mr. Bhavesh Dhirajlal Tanna (DIN: 03353445) as a “Director”, liable to Ordinary retire by rotation, who has offered himself for re- appointment. To appoint Mr. Suraj Mahadev Gaikwad (DIN: 11159369) as an Independent Director of 3 Special the company. 4 To approve Material Related Party Transactions entered into or proposed to be entered Ordinary into with related parties, in accordance with applicable laws and regulations. The Chairperson then addressed the shareholders sharing the vision for the Company and highlighting the areas where the Company may see exciting opportunities. Thereafter, the floor was opened for questions and answers for the shareholders and to share their views which were taken up by the Chairperson. Mr. Laxmikant Kabra, Chairperson placed on record his heartfelt thanks to all shareholders of the Company for sparing their time. The Chairperson then proposed a vote of thanks to the Members, Directors, Auditors, Management and the meeting was concluded at 04:54 P.M. IST. The quorum was present at the beginning and throughout the Meeting. This is for your information and records please. For Eiko LifeSciences Limited Chintan Doshi Company Secretary and Compliance Officer Membership No: A36190 Eiko LifeSciences Limited, CIN: L65993MH1977PLC258134 Registered Address: 604, Centrum, Opp. TMC Office, Near Satkar Grande Hotel, Wagle Estate, Thane MH 400604 Mobile No.: +919082668855; Email id: investor.rela(cid:415)ons@eikolifesciences.com website: www.eikolifesciences.com